Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anneke Hesseling

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|November 6, 2019
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosisTammy Meyers, Pearl Samson, Edward P Acosta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2021
Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational StudyDavit Baliashvili, Neel R Gandhi, Soyeon Kim, et al.
BMC Infectious Diseases|February 25, 2021
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trialAnne-Marie Demers, Soyeon Kim, Sara McCallum, et al.
The New England Journal of Medicine|October 3, 2019
Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum WomenAmita Gupta, Grace Montepiedra, Lisa Aaron, et al.
Trials|April 21, 2018
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trialChishala Chabala, Anna Turkova, Margaret J Thomason, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional StudyNishi Suryavanshi, Matthew Murrill, Amita Gupta, et al.
Contemporary Clinical Trials|September 7, 2025
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB designEkaterina V Kurbatova, Kelly E Dooley, Wendy Carr, et al.
The Lancet. Infectious Diseases|May 11, 2015
Towards early inclusion of children in tuberculosis drugs trials: a consensus statementSharon Nachman, Amina Ahmed, Farhana Amanullah, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Clinical Pharmacology and Therapeutics|September 10, 2020
Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of GenotypingKamunkhwala Gausi, Lubbe Wiesner, Jennifer Norman, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|November 6, 2019
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosisTammy Meyers, Pearl Samson, Edward P Acosta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2021
Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational StudyDavit Baliashvili, Neel R Gandhi, Soyeon Kim, et al.
BMC Infectious Diseases|February 25, 2021
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trialAnne-Marie Demers, Soyeon Kim, Sara McCallum, et al.
The New England Journal of Medicine|October 3, 2019
Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum WomenAmita Gupta, Grace Montepiedra, Lisa Aaron, et al.
Trials|April 21, 2018
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trialChishala Chabala, Anna Turkova, Margaret J Thomason, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional StudyNishi Suryavanshi, Matthew Murrill, Amita Gupta, et al.
Contemporary Clinical Trials|September 7, 2025
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB designEkaterina V Kurbatova, Kelly E Dooley, Wendy Carr, et al.
The Lancet. Infectious Diseases|May 11, 2015
Towards early inclusion of children in tuberculosis drugs trials: a consensus statementSharon Nachman, Amina Ahmed, Farhana Amanullah, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Clinical Pharmacology and Therapeutics|September 10, 2020
Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of GenotypingKamunkhwala Gausi, Lubbe Wiesner, Jennifer Norman, et al.
Pageof 3